Camp4 Therapeutics Corp (CAMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 12-2022 | |
| Cash Flows From Operating Activities | ||
| Net Income | -36,301 | -44,192 |
| Depreciation Amortization | 1,243 | 878 |
| Accounts payable and accrued liabilities | -965 | N/A |
| Other Working Capital | -957 | 1,704 |
| Other Operating Activity | 4,608 | 3,067 |
| Operating Cash Flow | $-32,372 | $-38,543 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -435 | -4,025 |
| Investing Cash Flow | $-435 | $-4,025 |
| Cash Flows From Financing Activities | ||
| Debt Issued | 706 | N/A |
| Debt Repayment | -354 | N/A |
| Common Stock Issued | 12 | N/A |
| Other Financing Activity | 0 | 100,157 |
| Financing Cash Flow | $364 | $100,157 |
| Beginning Cash Position | 84,536 | 26,947 |
| End Cash Position | 52,093 | 84,536 |
| Net Cash Flow | $-32,443 | $57,589 |
| Free Cash Flow | ||
| Operating Cash Flow | -32,372 | -38,543 |
| Capital Expenditure | -435 | N/A |
| Free Cash Flow | -32,807 | -38,543 |